MEETING NOTES : Dr. Redmond, Johns Hopkins Pituitary Day
Meeting Created:September 29, 2012, 12:07 PM
Baltimore
radiotherapy
- recurrence
- persistent hormone secretion
- inoperable
The last comments for
Signifor® (Pasireotide) is now Commercially Available
Has the Signifor helped you? Have any of the side effects gone away? I'm thinking of starting...
August 07, 2013 01:50:41 Jump to
The last comments for
was diagnosed with Cushing\'s syndrome last week,19th July 2013 and your story resonates with mine. It\'s...
July 25, 2013 01:04:10 Jump to
The last comments for
Thanks! Pretty valuable post!
June 26, 2013 03:24:50 Jump to
The last comments for
nice stuff
May 05, 2013 17:20:19 Jump to
The last comments for
Predictors of Mortality, CVD Risk in Cushing's Disease ID'd
Genuinely when someone doesn\'t know afterward its up to other people that they will help, so here it...
May 02, 2013 21:14:42 Jump to
Comments by IntenseDebate
Meeting Created:September 29, 2012, 12:07 PM
Baltimore
radiotherapy
Meeting Created:September 29, 2012, 11:41 AM
Baltimore
patient participation is most important
Meeting Created:September 29, 2012, 11:11 AM
Baltimore
pituitary lesions, surgery
Meeting Created:September 29, 2012, 10:49 AM
Baltimore
Cushing's, cyclical
Meeting Created:September 29, 2012, 10:28 AM
Baltimore
neuro-opthalmology
Meeting Created:September 29, 2012, 10:04 AM
Baltimore
Dr. Gary Wand
Meeting Created:September 29, 2012, 10:00 AM
Chantilly
Patient Education Day Agenda:
9:30 - 10:00 AM REGISTRATION AND BREAKFAST
10:00 - 10:20 AM What is the pituitary, and what can go wrong Gary Wand, MD
10:25 - 10:45 AM Vision problems in pituitary patients Prem Subramanian, MD, PhD
10:50 - 11:10 AM Pituitary Disease: a patient’s prospective Barbara Craven, PhD
11:15 - 11:35 AM Surgery for Pituitary tumors: what to expect Alfredo Quinones-Hinojosa, MD and Gary Gallia, MD, PhD
11:40 - 12:00 PM Nose problems before and after pituitary surgery Masaru Ishii, MD, PhD
12:05 - 12:25 PM When is radiotherapy needed for pituitary tumors Kirsten Redmond, MD
12:30 - 1:25 PM Lunch
1:30 - 3:00 PM Breakout sessions
1) Medical therapy (Wand/Salvatori)
2) Surgical therapy (Gallia)
3) Radiation therapy (Redmond/Lim)
4) Vision issues (Subramanian)
5) Nose issues (Ishii)
*This schedule is subject to change
October 1, 2012 at 6:30 PM eastern, Dr. Amir Hamrahian will answer our questions about Cushing's, pituitary or adrenal issues and Korlym (mifepristone) in BlogTalkRadio at http://www.blogtalkradio.com/cushingshelp/2012/10/01/dr-amir-hamrahian-answers-our-questions
You may listen live at the link above. The episode will be added to the Cushing's Help podcast after the show is over. Listen to the podcasts by searching for Cushings in the iTunes podcast area or click here: http://itunes.apple.com/podcast/cushingshelp-cushie-chats/id350591438
Dr. Hamrahian has had patients on Korlym for about 4 years.
Please submit your questions below or email them to CushingsHelp@gmail.com before Sunday, September 30.
From Dr. Hamrahian's bio at http://my.clevelandclinic.org/staff_directory/staff_display.aspx?doctorid=3676
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Amir H. Hamrahian, MD, is a Staff member in the Department of Endocrinology, Diabetes and Metabolism at Cleveland Clinic's main campus, having accepted that appointment in 2005. Prior to that appointment, he was also a clinical associate there for nearly five years.
His clinical interests include pituitary and adrenal disorders.
Dr. Hamrahian received his medical degree from Hacettepe University in Ankara, Turkey, and upon graduation was a general practitioner in the provinces of Hamadan and Tehran, Iran. He completed an internal medicine residency at the University of North Dakota, Fargo, and an endocrinology fellowship at Case Western Reserve University and University Hospitals, Cleveland.
In 2003, he received the Teacher of the Year award from Cleveland Clinic's Department of Endocrinology, Diabetes and Metabolism. Dr. Hamrahian speaks three languages -- English, Turkish and Farsi -- and is board-certified in internal medicine as well as endocrinology, diabetes and metabolism. He is a member of the Endocrine Society, Pituitary Society and the American Association of Clinical Endocrinologists.